Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole 1% topical cream for prevention and treatment of erlotinib-associated rash
2007-002895-32Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of metronidazole in toxicoderma (cADR), sponsored by Roche. Primary endpoint: Primary efficacy endpoint. Started Jul 2007; status: completed.
02
Drugs
metronidazole
03
Conditions
toxicoderma (cADR)
Beyond the preview
Go deeper on 2007-002895-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002895-32.